|
시장보고서
Advances in Disease Theranostics
|
Abstract
This research service analyses the latest developments that has occurred in
the field of theranostics, both from a technology and industry perspective.
Table of Contents
1 EXECUTIVE SUMMARY
- Research Scope and Methodology
- Research Scope
- Research Methodology
- Industry Overview; Trends; and Key Findings
- Industry Overview and Trends
- Noteworthy Developments
2 TECHNOLOGY ADOPTION FACTOR ANALYSIS
- Technology Primer
- Theranostics--A Whole New Concept
- What' s in Theranostics?--Assessing the Applications and Implications
- Some Exemplars of Theranostic Approaches
- Force Field Analysis
- The Driving Forces
- The Restraining Forces and Challenges
- Strategic Evaluation of the Competitive Environment (Analyst' s
Perspectives)
- A Strategic Evaluation of the Theranostics Sector--A SWOT Analysis
- Strategic Assessment of Competitive Landscape and Technology
Attractiveness of Theranostics
- Strategic Analysis of the Market Opportunities; Options; and Trends
- Theranostics Market Opportunity Analysis--A Concept Whose Influence
Cannot be Stifled
- Analysis of Options for Maximal Capitalization on Theranostics--Pharma
versus Diagnostic Companies
- Analysis of Current Trends and Future Outlook for Theranostics
3 CASE STUDIES OF GLOBAL INNOVATIONS IN THE THERANOSTICS SECTOR
- Corporate Innovations--World
- Predictive Tests Predict Right Therapy for the Right Patient--Denmark
- A ' Food Drug' a Day Could Keep Heart Diseases Away-Revolutionizing
Cardio-Theranostics--UK
- Analyzing Genes by Noninvasive Skin Sampling Inspires Novel Theranostic
Applications--USA
- From Novel Targets to Ideal Theranostics--USA
- Protein Arrays Paint an Individual' s ' Cell Signaling Portrait' -Taking
Theranostics to the Proteome Level--USA
- Simple Chemical Treatment Paves the Way for Neuronal Theranostics--USA
- From a Generic to a Genetic Approach-Customizing Cancer Treatments--USA
- Harnessing Protein Power to Advance Theranostics in Untapped Disease
Sectors-- USA
- Guiding CML Therapy with Standardized Companion Diagnostics--USA
- Academic Innovations--World
- From Hydrogels to Theranostics-A Whole New Approach to Multiplexed
Diagnosis--USA
- ' Rapid' Tracking of Biomarkers in AML Therapy-- USA
4 PATENTS ANALYSIS AND KEY CONTACTS
- Key Patents in the Theranostics Domain (2005 to 2008)
- Key Corporate Patents--American Patents (USPTO)
- Key Corporate Patents--World Patents (WIPO)
- Key Academic Patents
- Geographical Analysis of Patent Distribution-World Theranostics Sector
- Key Contacts
- Key Industry Contacts
- Key Academic Contacts
5 DECISION SUPPORT DATABASES
- Database Tables
- Total Healthcare Expenditure--World (2002 to 2012)
- Pharmaceutical R&D Expenditure--World (2002 to 2012)
- Number of Physicians--World (2002 to 2012)
- Number of Hospitals--World (2002 to 2012)
- Incidence of Breast Cancer--World (2002 to 2012)
|
